Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C28H24FN3O9S |
| Molecular Weight | 597.568 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC5=CC=C(F)C=C5OS(O)(=O)=O)C=C3)=C2C=C1OC
InChI
InChIKey=VFXIPUKNLGLBNJ-UHFFFAOYSA-N
InChI=1S/C28H24FN3O9S/c1-38-24-14-19-21(15-25(24)39-2)30-12-9-22(19)40-18-6-4-17(5-7-18)31-26(33)28(10-11-28)27(34)32-20-8-3-16(29)13-23(20)41-42(35,36)37/h3-9,12-15H,10-11H2,1-2H3,(H,31,33)(H,32,34)(H,35,36,37)
| Molecular Formula | C28H24FN3O9S |
| Molecular Weight | 597.568 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 05:59:01 GMT 2025
by
admin
on
Wed Apr 02 05:59:01 GMT 2025
|
| Record UNII |
MC20MXE412
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
MC20MXE412
Created by
admin on Wed Apr 02 05:59:01 GMT 2025 , Edited by admin on Wed Apr 02 05:59:01 GMT 2025
|
PRIMARY | |||
|
86269462
Created by
admin on Wed Apr 02 05:59:01 GMT 2025 , Edited by admin on Wed Apr 02 05:59:01 GMT 2025
|
PRIMARY | |||
|
1628530-40-4
Created by
admin on Wed Apr 02 05:59:01 GMT 2025 , Edited by admin on Wed Apr 02 05:59:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
IC50
|
||
|
TARGET -> INHIBITOR |
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
FECAL; URINE
|
||
|
PARENT -> METABOLITE |
MAJOR
PLASMA
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Biological Half-life | PHARMACOKINETIC |
|
|
|||
| Tmax | PHARMACOKINETIC |
|
|
|||